title: Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative.
abstract: 1. We studied the interaction of the cardiotonic compound DPI 201-106 (4-[3'-(4''-benzhydryl-1''-piperazinyl)-2'-hydroxypropoxy]-1H-indole-2- carbonitrile; DPI) and its derivative BDF 8784 (2-methyl-4-[3'-(4''-benzhydryl- 1''-piperazinyl)-2'-hydroxypropoxy]-1H-indole; BDF) in isolated right ventricular papillary muscles of guinea-pig heart. 2. In contrast to the cardiotonic DPI, the methyl-indole derivative lacked a positive inotropic effect and even caused negative inotropic effects in concentrations above 1 microM. At 10 microM BDF significantly reduced the force of contraction and dV/dtmax, but did not affect action potential duration (APD). 3. Pretreatment of papillary muscles with BDF prevented the positive inotropic action of DPI in a concentration-dependent, but non-competitive fashion. At 10 microM, BDF prevented the inotropic effect of racemic DPI and shortened the DPI-induced prolongation of action potential duration. BDF similarly affected the inotropic and APD-prolonging effects of the sea anemone polypeptide ATX II. 4. In cardiac myocytes, DPI induced a tetrodotoxin (TTX)-sensitive, slowly inactivating inward current. The slow decay of this current was enhanced by BDF. In cells pretreated with BDF, DPI was not effective. BDF alone depressed the sodium and the calcium current. 5. In conclusion, the non-inotropic methyl-indole derivative BDF interacts with DPI noncompetitively at the sodium channels to abolish the inotropic and APD-prolonging effects of DPI, emphasizing the importance of the substituent in position 2 of the indole moiety for this effect.
authors.affiliation: Department of Pharmacology, Beiersdorf AG, Hamburg, F.R.G.
authors.forename: B I
authors.initials: BI
authors.lastname: Armah
authors.forename: T
authors.initials: T
authors.lastname: Pfeifer
authors.forename: U
authors.initials: U
authors.lastname: Ravens
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002316:Cardiotonic Agents / Q000037:antagonists & inhibitors*; D003064:Cnidarian Venoms / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D009200:Myocardial Contraction / Q000187:drug effects; D010210:Papillary Muscles / Q000187:drug effects; D010879:Piperazines / Q000037:antagonists & inhibitors* / Q000494:pharmacology*
chemical_list: D002316:Cardiotonic Agents; D003064:Cnidarian Venoms; D007211:Indoles; D010879:Piperazines; C060322:BDF 8784; C028800:toxin II (Anemonia sulcata); C046261:DPI 201-106